[object Object]

LES 13ÈMES UNIVERSITÉS D’HÉMATOLOGIE JANSSEN VIENNENT À VOUS !

VOUS VOUS POSEZ DES QUESTIONS PRATIQUES SUR LES HÉMOPATHIES MALIGNES ?

DES EXPERTS Y RÉPONDENT EN MOINS DE 3 MINUTES AU TRAVERS DE LA SÉRIE DE VIDÉOS PAROLES D’EXPERTS DES E-UH12.

En vedette cette semaine :

Myélome multiple - A quel patient proposer une double autogreffe en 2020/2021 ?

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

CP-222032-04/2021

Vous souhaitez être infromé(e) lorsqu'une nouvelle vidéo est disponible ?

Myélome Multiple

Myélome multiple - Doit-on obligatoirement alterner les "mécanismes d'action "pour tous les patients à la première rechute ?

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

CP-222059-04/2021

Myélome multiple - Quand décider de la reprise d'un traitement de la maladie à la première rechute ?

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

CP-220287-04/2021

Myélome multiple - Quels sont les principaux conseils pratiques pour assurer la délivrance d'un traitement optimal du myélome chez le sujet âgé ?

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

CP-222060-04/2021

Myélome multiple - Les modalités pratiques de l'autogreffe

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

CP-220285-04/2021

Myélome multiple - L’autogreffe, jusqu’à quel âge la proposer ?

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

CP-222032-04/2021

Myélome multiple - A quels patients proposer une double autogreffe en 2020/2021 ?

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

CP-222034-04/2021

Leucémie lymphoïde chronique

LLC - Faut-il évaluer le statut iGHV chez tous les patients ?

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

CP-222171-04/2021

LLC - Quels patients restent candidats à l'immuno-chimiothérapie en 2020/2021 ?

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

CP-222125-04/2021

Quelle attitude pratique face à une cytopénie auto-immune associée à la LLC ?

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

CP-222061-04/2021

LLC et mesure de la maladie résiduelle - Quelle utilisation en pratique en 2020/2021 ?

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

CP-222180-04/2021

Amylose

Quels sont les éléments clés du bilan au diagnostic initial d'une amylose AL ?

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

CP-222185-04/2021

En pratique, quel suivi clinico-biologique pour une amylose AL ?

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

CP-222191-04/2021

Maladie de Waldenström

Jusqu'où aller dans le bilan initial de la maladie de Waldenström ?

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

CP-222199-04/2021

Lymphomes

Usages et perspectives sur le rôle de la TEP-FDG dans la prise en charge des lymphomes

It seems your browser is blocking 3rd party cookies which are required to display videos. To resolve this issue, please update your cookie settings to allow these 3rd party cookies.

CP-222201-04/2021